Diana Aristizabal
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 39.6% of the total. Reporting peaked in 2023 at $1,234 and has fallen 67.4% since, to $402 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $30.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Phathom Pharmaceuticals, Inc.$786
- Redhill Biopharma Inc.$391
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$362
- Neurelis, Inc.$270
- Alkermes, Inc.$159
- plus $879 from 14 others
What the payments were for
- Food & beverage$4,714100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $1,868 |
| Phathom Pharmaceuticals, Inc. | 8 | $786 |
| Redhill Biopharma Inc. | 18 | $391 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $362 |
| Neurelis, Inc. | 3 | $270 |
| Alkermes, Inc. | 8 | $159 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $140 |
| Scilex Pharmaceuticals Inc. | 7 | $132 |
| Idorsia Pharmaceuticals US Inc | 6 | $105 |
| Lilly USA, LLC | 6 | $90 |
| Orexo US, Inc. | 4 | $70 |
| Novo Nordisk | 3 | $60 |
| EMD Serono, Inc. | 2 | $54 |
| Pfizer | 2 | $53 |
| IBSA Pharma Inc. | 2 | $41 |
| GRT US Holding, Inc. | 2 | $38 |
| Johnson & Johnson | 1 | $30 |
| Fidia Pharma USA Inc. | 1 | $28 |
| Forte Bio-pharma LLC | 1 | $22 |
| Indivior Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,714 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Miami
- Patrick SzarazMiami$327K
- Yamila MelendezMiami$212K
- Suzan RosenMiami$129K
- Felipe NovoaMiami$110K
- Pamela DudkiewiczMiami$89K
- Stacy FeemsterMiami$51K
- Estrella Moreno RodriguezMiami$30K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.